Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In Vitro.

coronary artery disease coronary vessels gene expression genome-wide association study polymorphism, single nucleotide

Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
11 Apr 2024
Historique:
medline: 11 4 2024
pubmed: 11 4 2024
entrez: 11 4 2024
Statut: aheadofprint

Résumé

CALCRL (calcitonin receptor-like) protein is an important mediator of the endothelial fluid shear stress response, which is associated with the genetic risk of coronary artery disease. In this study, we functionally characterized the noncoding regulatory elements carrying coronary artery disease that risks single-nucleotide polymorphisms and studied their role in the regulation of To functionally characterize the coronary artery disease single-nucleotide polymorphisms harbored around the gene We demonstrate that the regulatory element harboring rs880890 exhibits high enhancer activity and shows significant allelic bias. The A allele was favored over the G allele, particularly under shear stress conditions, mediated through alterations in the HSF1 (heat shock factor 1) motif and binding. CRISPR deletion of rs880890 enhancer resulted in downregulation of Overall, our results demonstrate the existence of an endothelial-specific HSF (heat shock factor)-regulated transcriptional enhancer that mediates

Sections du résumé

BACKGROUND UNASSIGNED
CALCRL (calcitonin receptor-like) protein is an important mediator of the endothelial fluid shear stress response, which is associated with the genetic risk of coronary artery disease. In this study, we functionally characterized the noncoding regulatory elements carrying coronary artery disease that risks single-nucleotide polymorphisms and studied their role in the regulation of
METHODS UNASSIGNED
To functionally characterize the coronary artery disease single-nucleotide polymorphisms harbored around the gene
RESULTS UNASSIGNED
We demonstrate that the regulatory element harboring rs880890 exhibits high enhancer activity and shows significant allelic bias. The A allele was favored over the G allele, particularly under shear stress conditions, mediated through alterations in the HSF1 (heat shock factor 1) motif and binding. CRISPR deletion of rs880890 enhancer resulted in downregulation of
CONCLUSIONS UNASSIGNED
Overall, our results demonstrate the existence of an endothelial-specific HSF (heat shock factor)-regulated transcriptional enhancer that mediates

Identifiants

pubmed: 38602103
doi: 10.1161/ATVBAHA.123.318964
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ilakya Selvarajan (I)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Miika Kiema (M)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Ru-Ting Huang (RT)

Department of Medicine, The University of Chicago, IL (R.-T.H., J.L., J.Z., Y.F.).

Jin Li (J)

Department of Medicine, The University of Chicago, IL (R.-T.H., J.L., J.Z., Y.F.).

Jiayu Zhu (J)

Department of Medicine, The University of Chicago, IL (R.-T.H., J.L., J.Z., Y.F.).

Petri Pölönen (P)

Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio. (P.P., M.H.).

Tiit Örd (T)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Kadri Õunap (K)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Mehvash Godiwala (M)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Anna Kathryn Golebiewski (AK)

Department of Cellular and Molecular Medicine, College of Medicine, The University of Arizona, Tucson (A.K.G., L.K.S., C.E.R.).

Aarthi Ravindran (A)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Kiira Mäklin (K)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Anu Toropainen (A)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Lindsey K Stolze (LK)

Department of Cellular and Molecular Medicine, College of Medicine, The University of Arizona, Tucson (A.K.G., L.K.S., C.E.R.).

Maximiliano Arce (M)

Department of Immunology, Genetics and Pathology, Uppsala University, Sweden (M.A., P.U.M.).

Peetra U Magnusson (PU)

Department of Immunology, Genetics and Pathology, Uppsala University, Sweden (M.A., P.U.M.).

Stephen White (S)

Faculty of Medical Sciences, Biosciences Institute, Newcastle University, United Kingdom (S.W.).

Casey E Romanoski (CE)

Department of Cellular and Molecular Medicine, College of Medicine, The University of Arizona, Tucson (A.K.G., L.K.S., C.E.R.).

Merja Heinäniemi (M)

Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio. (P.P., M.H.).

Johanna P Laakkonen (JP)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Yun Fang (Y)

Department of Medicine, The University of Chicago, IL (R.-T.H., J.L., J.Z., Y.F.).

Minna Kaikkonen-Määttä (M)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio. (I.S., M.K., T.Ö., K.Õ., M.G., A.R., K.M., A.T., J.P.L., M.K.-M.).

Classifications MeSH